135 related articles for article (PubMed ID: 11373152)
1. Antisense oligonucleotide inhibition of type II phospholipase A2 expression, release and activity in vitro.
Lappas M; Munns MJ; King RG; Rice GE
Placenta; 2001 May; 22(5):418-24. PubMed ID: 11373152
[TBL] [Abstract][Full Text] [Related]
2. Contribution of type II PLA2 to prostaglandin formation: a study using a type II PLA2 specific inhibitor SB 203347.
Munns MJ; King RG; Rice GE
Prostaglandins Other Lipid Mediat; 1999 Jul; 57(5-6):361-70. PubMed ID: 10480490
[TBL] [Abstract][Full Text] [Related]
3. Regulation of prostaglandin F2alpha by the specific inhibition of secretory type II phospholipase A2: implications for the management of premature labour.
Munns MJ; King RG; Rice GE
Gynecol Obstet Invest; 1999; 48(1):22-7. PubMed ID: 10394087
[TBL] [Abstract][Full Text] [Related]
4. Suppression of human synovial fibroblast 85 kDa phospholipase A2 by antisense reduces interleukin-1 beta induced prostaglandin E2.
Roshak A; Mochan E; Marshall LA
J Rheumatol; 1996 Mar; 23(3):420-7. PubMed ID: 8832976
[TBL] [Abstract][Full Text] [Related]
5. Secretory type II PLA2 immunoreactivity and PLA2 enzymatic activity in human gestational tissues before, during and after spontaneous-onset labour at term.
Munns MJ; Farrugia W; King RG; Rice GE
Placenta; 1999 Jan; 20(1):21-6. PubMed ID: 9950141
[TBL] [Abstract][Full Text] [Related]
6. Reduction of human recombinant type II phospholipase A2 and prostaglandin F2 alpha release by microtubule depolymerizing agents.
Munns MJ; King RG; Rice GE
Clin Exp Pharmacol Physiol; 1999 Mar; 26(3):230-5. PubMed ID: 10081619
[TBL] [Abstract][Full Text] [Related]
7. Distinct phospholipase A2 enzymes regulate prostaglandin E2 and F2alpha production by bovine endometrial epithelial cells.
Tithof PK; Roberts MP; Guan W; Elgayyar M; Godkin JD
Reprod Biol Endocrinol; 2007 Apr; 5():16. PubMed ID: 17459165
[TBL] [Abstract][Full Text] [Related]
8. Developmental maturation of baboon placental trophoblast: expression of messenger ribonucleic acid and protein levels of cytosolic and secretory phospholipases A2.
Rosenthal MD; Albrecht ED; Pepe GJ
J Clin Endocrinol Metab; 1998 Aug; 83(8):2861-7. PubMed ID: 9709960
[TBL] [Abstract][Full Text] [Related]
9. Release of Type II phospholipase A2 immunoreactivity and phospholipase A2 enzymatic activity from human placenta.
Farrugia W; Rice GE; Wong MH; Scott KF; Brennecke SP
J Endocrinol; 1997 Apr; 153(1):151-7. PubMed ID: 9157179
[TBL] [Abstract][Full Text] [Related]
10. Mouse group X secretory phospholipase A2 induces a potent release of arachidonic acid from spleen cells and acts as a ligand for the phospholipase A2 receptor.
Morioka Y; Saiga A; Yokota Y; Suzuki N; Ikeda M; Ono T; Nakano K; Fujii N; Ishizaki J; Arita H; Hanasaki K
Arch Biochem Biophys; 2000 Sep; 381(1):31-42. PubMed ID: 11019817
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the secretory phospholipase A2 that mediates prostaglandin production in mast cells.
Reddy ST; Winstead MV; Tischfield JA; Herschman HR
J Biol Chem; 1997 May; 272(21):13591-6. PubMed ID: 9153207
[TBL] [Abstract][Full Text] [Related]
12. PGE2 release is independent of upregulation of Group V phospholipase A2 during long-term stimulation of P388D1 cells with LPS.
Kessen UA; Schaloske RH; Stephens DL; Killermann Lucas K; Dennis EA
J Lipid Res; 2005 Nov; 46(11):2488-96. PubMed ID: 16150819
[TBL] [Abstract][Full Text] [Related]
13. Cytosolic 85-kDa phospholipase A2-mediated release of arachidonic acid is critical for proliferation of vascular smooth muscle cells.
Anderson KM; Roshak A; Winkler JD; McCord M; Marshall LA
J Biol Chem; 1997 Nov; 272(48):30504-11. PubMed ID: 9374544
[TBL] [Abstract][Full Text] [Related]
14. Antisense inhibition of group II phospholipase A2 expression blocks the production of prostaglandin E2 by P388D1 cells.
Barbour SE; Dennis EA
J Biol Chem; 1993 Oct; 268(29):21875-82. PubMed ID: 8408042
[TBL] [Abstract][Full Text] [Related]
15. Contribution of type II phospholipase A2 to in vitro phospholipase A2 enzymatic activity in human term placenta.
Rice GE; Wong MH; Farrugia W; Scott KF
J Endocrinol; 1998 Apr; 157(1):25-31. PubMed ID: 9614354
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of type II, IV and cytosolic PLA2 messenger RNA in human intrauterine tissues at term.
Freed KA; Moses EK; Brennecke SP; Rice GE
Mol Hum Reprod; 1997 Jun; 3(6):493-9. PubMed ID: 9239738
[TBL] [Abstract][Full Text] [Related]
17. Effect of the choline acetyltransferase inhibitor (2-benzoylethyl)-trimethylammonium iodide (BETA) on human placental prostaglandin release and phospholipase A2 activity.
Chen YS; King RG; Rook TJ; Brennecke SP
Placenta; 1993; 14(6):627-40. PubMed ID: 8153085
[TBL] [Abstract][Full Text] [Related]
18. Relative abundance of human placental phospholipase A2 messenger RNA in late pregnancy.
Aitken MA; Rice G; Brennecke S
Prostaglandins; 1992 Apr; 43(4):361-70. PubMed ID: 1376934
[TBL] [Abstract][Full Text] [Related]
19. Posttranscriptional effect of insulin-like growth factor-I on interleukin-1beta-induced type II-secreted phospholipase A2 gene expression in rabbit articular chondrocytes.
Jacques C; Béréziat G; Humbert L; Olivier JL; Corvol MT; Masliah J; Berenbaum F
J Clin Invest; 1997 Apr; 99(8):1864-72. PubMed ID: 9109430
[TBL] [Abstract][Full Text] [Related]
20. Bacterial endotoxin increases type II phospholipase A2 immunoreactive content and phospholipase A2 enzymatic activity in human choriodecidua.
Nguyen HT; Rice GE; Farrugia W; Wong M; Brennecke SP
Biol Reprod; 1994 Mar; 50(3):526-34. PubMed ID: 8167224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
